George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Interesting that they've also updated the number of shares in issue. I mentioned here on Weds that is was wrong as it didn't sccount for the recent placing shares.
Maybe they look on here.
They need to update the number of shares. Shown on the website as 490million. Should be 513million after the placing.
Look at the effect on Biondvax SP!
I've only sold enough to recover my capital.
I still have a decent holding and am very much looking foward to dividends.
I think that sometimes the best explanation is just "that is how AIM works". I've been in since 6p and for the first time "sold the news" at 29p.
It feels counterintuitive but it seems to happen often.
People will buy back in over the next week or so.
I've been invested about 18 months but wouldn't invest now for all the reasons ForFXSake gives but also the two placings in the last year that suggest the business model is broken. They are unable to fund their R&D from milestone payments and licensing agreements because they have none.
I think the future of the company rests entirely on the new CEO. They have to hit the ground running and achieve something significant within 6 months or there will be more placings. I get the feeling that Blackwell doesn't really want the job of CEO so expect nothing to happen while he is in charge.
Covid is also a concern. With so much research going into it's treatment I am worried NFX will be left behind as they have so little money. A treatment for IPF could come out of covid research elsewhere that would make NXP002 obsolete before they ever get a deal done.
Full disclosure, I sold most of my holdings here in the summer so only have 100k shares left which I will leave until the end but regard them now as a punt.
I'm also looking at this stock. Did you watch the presentation that followed ORPH and Cathal said he was a shareholder here?
That was good enough for me to start looking in here.
Looks like they've recently done a placing and have a credit facility. The CEO seems very confident they will hit pofitability this year.
Interims show cash of £4.3 mil end of Septmeber and operating loss of £0.9m for H1. Losses are reducing.
Do existing shareholders share the CEOs optimism about profitability coming this year?
Does anyone have a list of major share holders? I can't see one on their website.
Can I ask why people are so confident in Blackwell when he doesn't own shares in the company and only takes a small salary?
Accoring to the accounts he is on £45k which seems very low for a Chairman/CEO.
The same can be said for Keegan who owns no shares and only earns £6k.
Just how much effort do they put in to making NFX successful with so little skin in the game.
It would be a very good sign to see them both buy a chunk of shares at this cheap price.
ETX was a strange one. I think most of the board stood down and the SP went from 4p to 20p.
They also did a deal in the IPF space earlier this month. Lets hope history repeats itself here.
I'm wondering if there was some conflict within NFX about the speed vs quality of an NXP2 deal.
Dan said ealier this year that he wanted the best deal not the fastest.
Maybe the Chairman thinks time is more important. The placing money wont last forever.
A suboptimal deal done soon maybe what is needed.
"Perfection is the Enemy of Progress"
chablard, taken directly from the RNS:
"Company has also signed a new agreement with VistaGen Therapeutics, Inc for an early stage collaboration with immediate revenue, upside and the potential to extend this agreement."
"immediate revenue" sounds like an up front payment.
As always we could do with some more details.
I think the valuation they are using for Imutex comes from Cathal talking about Merck's aquisition of Themis for a sum he believes to be around 200 to 300 million, and Themis being a very similar company to Imutex.
Question for moniman. If someone offered £300 million for Imutex tomorrow, all to be paid out in a dividend should Cathal take it?
The alternative being the Nasdaq option.
Also this wasn't really news.
From watching Cathal's presentations and the now deleted tweet it was known for a while that this was coming today.
To be clear Northseatiger, I understood that to be a hyperthetical situation where they could redo the last placing in a different way.
I expect that in the near term the company is going to start generating serious cash and in the medium term there is a much higher chance of a dividend than a placing.
We can clarify when a replay is put up, but I think it was a discussion about the last placing that has confused a poster.
Cathal said he had underestimated the appetite for Primary Bid and if they were to do it again he would allocate more to retail investors.
I find it always worth watching Cathal's presentation twice as there is alot of good stuff to take in.
I think Cathal's plan of testing business staff in the city is spot on.
I'm from London and I along with friends am convinced that the London Underground was spreading Covid faster than anything else.
Most of these city staff travel on the tube which at the moment is running at a fraction of it's capacity.
Finding out which staff can safely travel to work is well worth the cost of the test.
@raharh,
I saw the smile as well. He looked genuinely excited about what is coming.
Watch the last presentation. The company is always for sale but Cathal wants substantially more than £100 million for it.
Presumably that wouldn't include Imutex either.
I would agree that the company is much stronger now. There are now so many different aspects to the business and people expect that they will hit or exceed the revenue target for the year.
The failure to break 2p is becoming a bit repetative. People will continue sell when ever it goes over because they know it will be back below again soon.
However the chart is begining to look positive to my non-expert eye. The 50 day moving average is rising for the first time in nearly a year and looks like it will cross the 200 day moving average later this month. If that is combined with more good news it maybe enough to get past 2p.
Any chart experts watching who can comment?
Long time SKIN holder here and looking at MWG.
I like the idea of real time remote monitoring of water. That is how most industries are monitoring things and in most cases prefer to pay a third party to do it for them.
My query is how quickly the system can be adapted to a new threat. For example if the MWG monitoring sytem had been installed across the whole UK and working last year. In January we start hearing about this new virus in China.
How quickly could the whole system have been updated to detect it?
Could it have offered us an early warning in February for example and allowed an earlier response and less spread of the virus?
Doesn't have to be covid specific. I'm thinking of the next pandemic. It would be nice if in 5 or 10 years time when another virus emerges somewhere, we could react faster and not have to shut the economy down for three months.